Evidence mapPaperPMID 41465247Full record

ArticleInternational journal of molecular sciences2025

Novel Mono-Substituted 4

Eleftherios Charissopoulos, Panayiotis A Koutentis, Andreas S Kalogirou, Eleni Pontiki

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Eleftherios CharissopoulosLaboratory of Pharmaceutical Chemistry, Faculty of Health Sciences, School of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0009-0005-6199-7267
Panayiotis A KoutentisDepartment of Chemistry, University of Cyprus, P.O. Box 20537, Nicosia 1678, Cyprus.ORCID 0000-0002-4652-7567
Andreas S KalogirouDepartment of Life Sciences, School of Sciences, European University Cyprus, 6 Diogenis Str., Engomi, P.O. Box 22006, Nicosia 1516, Cyprus.ORCID 0000-0002-5476-5805
Eleni PontikiLaboratory of Pharmaceutical Chemistry, Faculty of Health Sciences, School of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0003-0099-5653

Funding

This research was funded by the Cyprus Research Promotion Foundation, grant numbers ΣΤΡΑΤΗΙΙ/0308/06, NEKYP/0308/02 ΥΓΕΙΑ/0506/19 and ΕΝΙΣΧ/0308/83. ΣΤΡΑΤΗΙΙ/0308/06, NEKYP/0308/02 ΥΓΕΙΑ/0506/19 and ΕΝΙΣΧ/0308/83
6 · The paper itself

Abstract

Τhe synthesis of a novel series of mono-substituted 4

Indexed as

AntioxidantsLipoxygenaseLipoxygenase InhibitorsThiadiazinesBiphenyl CompoundsGlycine maxLipid PeroxidationMolecular Docking SimulationPicratesStructure-Activity Relationship1,1-diphenyl-2-picrylhydrazylAntioxidantsBiphenyl CompoundsLipoxygenaseLipoxygenase InhibitorsPicratesThiadiazines1,2,6-thiadiazineanti-inflammatoryantioxidantsheterocyclelipoxygenase

Identifiers

PMID41465247
PMCPMC12733323

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.